[Barret esophagus--molecular biology].
Increasing incidence of adenocarcinoma of the esophagus is nowadays observed in western countries. Estimation of the unique molecules may, in the future, lead to early diagnostics of pathological changes in the Barret esophagus and identification of the patient at risk from cancerogenesis. The aim of this study is to explain terminology of Barret esophagus, basis of histopatology, diagnostics and to show molecules which have crucial significance in cancerogenesis.
Włodarczyk
Janusz
J
Oddział Chirurgii Klatki Piersiowej Krakowski Szpital Specjalistyczny im. Jana Pawła II, Kraków. j.wlodarczyk@szpitaljp2.krakow.pl
D001471:Barrett Esophagus / Q000150:complications / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology*; D004938:Esophageal Neoplasms / Q000209:etiology / Q000517:prevention & control*; D016147:Genes, Tumor Suppressor; D005819:Genetic Markers; D006801:Humans; D009857:Oncogenes / Q000235:genetics; D012307:Risk Factors; D009626:Terminology as Topic
D005819:Genetic Markers